Clinical Effects of Hospital–Family Collaborative Cardiac Rehabilitation Training on Patients with Heart Failure after Cardiac Valve Prostheses

Background: Affected by factors, such as patients' age, course of disease, and underlying diseases, patients have high complications after cardiac valve replacement. This study applied hospital–family collaborative cardiac rehabilitation training to patients with heart failure undergoing cardiac valve prostheses and explored the clinical effect to provide guidance for postoperative rehabilitation. Methods: The clinical data of 213 patients with heart failure admitted to our hospital from January 2023 to January 2024 were retrospectively analyzed. After 12 cases who did not meet the inclusion criteria were excluded, 201 cases were finally included. In accordance with different nursing methods, patients were divided into reference group (n = 102) and observation group (n = 99). The reference group received routine nursing program, whereas the study group adopted hospital–family collaborative cardiac rehabilitation training on the basis of routine nursing. The levels of cardiac function indices [left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV) and stroke volume (SV)], quality of life, cardiovascular risk factors [total cholesterol (TC), triglyceride (TG), and fasting blood glucose (FBG)] and the rehospitalization rate were compared between the two groups. Results: Before management, the levels of LVEF, LVEDV, LVESV, SV, quality-of-life scores, TC, TG, and FBG in the two groups were similar (p > 0.05). After management, the observation group had higher levels of LVEF, LVEDV, LVESV, and SV (p < 0.001); a better quality of life (p < 0.001); lower levels of TC, TG, and FBG (p < 0.001); and a lower rehospitalization rate (p < 0.05) than the reference group. Conclusion: Hospital–family collaborative cardiac rehabilitation training seems to improve the cardiac function indices of patients undergoing cardiac valve prostheses, and it has a certain clinical application value. However, the results should be promoted with caution, and more studies are needed to verify them.